
    
      Subjects will be randomized into one of four groups: exercise training, exercise training and
      metformin, metformin alone, or control arm. All subjects will have lifestyle measurements,
      interviews regarding activity level, diet questionnaires, and blood tests.

      Subjects randomized to exercise training will participate in two supervised exercise sessions
      per week with an exercise physiologist for 3 months. They will also be asked to exercise on
      their own for up to an additional 120 minutes each week.

      Subjects randomized to exercise training and metformin will participate in two supervised
      exercise sessions per week and will take metformin. Metformin will be taken once daily for
      the first two weeks and then twice daily for 3 months.

      Subjects randomized to metformin will take metformin once daily for the first two weeks and
      then twice daily.

      Subjects on the control arm will receive a packet of educational information on nutrition and
      physical activity developed by the National Cancer Institute and American Cancer Society. In
      addition to education information, they will be offered two supervised sessions with an
      exercise physiologist as well as a pedometer 3 months after enrollment in the study.
    
  